GSK (LON:GSK) Share Price Crosses Above 200 Day Moving Average - What's Next?

Shares of GSK plc (LON:GSK - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,421.59 ($19.08) and traded as high as GBX 1,495.50 ($20.07). GSK shares last traded at GBX 1,402.50 ($18.83), with a volume of 13,469,607 shares trading hands.

Analysts Set New Price Targets

GSK has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a GBX 1,450 ($19.46) price objective on shares of GSK in a research note on Tuesday, July 8th. Berenberg Bank reiterated a "hold" rating and issued a GBX 1,600 ($21.48) target price on shares of GSK in a report on Friday. JPMorgan Chase & Co. restated an "underweight" rating on shares of GSK in a report on Friday. Finally, Shore Capital reaffirmed a "buy" rating and issued a GBX 2,000 ($26.85) price target on shares of GSK in a research report on Friday.

GSK Price Performance

The stock has a market cap of £54.70 billion, a P/E ratio of 21.78, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a current ratio of 0.81, a quick ratio of 0.73 and a debt-to-equity ratio of 114.64. The company's fifty day simple moving average is GBX 1,435.32 and its 200-day simple moving average is GBX 1,422.13.

GSK (LON:GSK - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported GBX 44.90 ($0.60) earnings per share for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. As a group, sell-side analysts forecast that GSK plc will post 175.980975 EPS for the current year.

Insider Buying and Selling at GSK

In other news, insider Wendy Becker bought 545 shares of GSK stock in a transaction dated Friday, June 20th. The shares were bought at an average price of GBX 1,435 ($19.26) per share, for a total transaction of £7,820.75 ($10,497.65). Also, insider Emma Walmsley sold 5,473 shares of the company's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of GBX 1,449 ($19.45), for a total transaction of £79,303.77 ($106,448.01). Insiders have purchased 1,905 shares of company stock worth $2,732,835 over the last three months. Company insiders own 1.61% of the company's stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.